Transgenic GDNF Positively Influences Proliferation, Differentiation, Maturation and Survival of Motor Neurons Produced from Mouse Embryonic Stem Cells.
Embryonic stem cells (ESC) are pluripotent and thus can differentiate into every cell type present in the body. Directed differentiation into motor neurons (MNs) has been described for pluripotent cells. Although neurotrophic factors promote neuronal survival, their role in neuronal commitment is elusive. Here, we developed double-transgenic lines of mouse ESC (mESC) that constitutively produce glial cell line-derived neurotrophic factor (GDNF) and also contain a GFP reporter, driven by HB9, which is expressed only by postmitotic MNs. After lentiviral transduction, ESC lines integrated and expressed the human GDNF (hGDNF) gene without altering pluripotency markers before differentiation. Further, GDNF-ESC showed significantly higher spontaneous release of this neurotrophin to the medium, when compared to controls. To study MN induction, control and GDNF cell lines were grown as embryoid bodies and stimulated with retinoic acid and Sonic Hedgehog. In GDNF-overexpressing cells, a significant increase of proliferative Olig2+ precursors, which are specified as spinal MNs, was found. Accordingly, GDNF increases the yield of cells with the pan motor neuronal markers HB9, monitored by GFP expression, and Isl1. At terminal differentiation, almost all differentiated neurons express phenotypic markers of MNs in GDNF cultures, with lower proportions in control cells. To test if the effects of GDNF were present at early differentiation stages, exogenous recombinant hGDNF was added to control ESC, also resulting in enhanced MN differentiation. This effect was abolished by the co-addition of neutralizing anti-GDNF antibodies, strongly suggesting that differentiating ESC are responsive to GDNF. Using the HB9::GFP reporter, MNs were selected for electrophysiological recordings. MNs differentiated from GDNF-ESC, compared to control MNs, showed greater electrophysiological maturation, characterized by increased numbers of evoked action potentials (APs), as well as by the appearance of rebound APs, sag inward rectification, spike frequency adaptation and spontaneous synaptic potentials. Upon challenge with kainate, GDNF-overexpressing cells are more resistant to excitotoxicity than control MNs. Together these data indicate that GDNF promotes proliferation of MN-committed precursors, promotes neuronal differentiation, enhances maturation, and confers neuroprotection. GDNF-expressing ESC can be useful in studies of development and disease.
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de MéxicoMexico City, Mexico; Laboratorio de Reprogramación Celular del Instituto de Fisiología Celular, Universidad Nacional Autónoma de México en el Instituto Nacional de Neurología y Neurología "Manuel Velasco Suárez"Mexico City, Mexico.
Daniel
D
Cortés
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de México Mexico City, Mexico.
Yolanda
Y
Robledo-Arratia
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de México Mexico City, Mexico.
Ricardo
R
Hernández-Martínez
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de México Mexico City, Mexico.
Itzel
I
Escobedo-Ávila
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de México Mexico City, Mexico.
José
J
Bargas
Instituto de Fisiología Celular-Neurociencias, Universidad Nacional Autónoma de MéxicoMexico City, Mexico; Laboratorio de Reprogramación Celular del Instituto de Fisiología Celular, Universidad Nacional Autónoma de México en el Instituto Nacional de Neurología y Neurología "Manuel Velasco Suárez"Mexico City, Mexico.
Iván
I
Velasco
committed neural precursors; electrophysiological maturation; excitotoxicity; glial cell line-derived neurotrophic factor; neuroprotection; spinal motor neuron
J Neurosci. 2001 Oct 15;21(20):8108-18
11588183
Cell Transplant. 2009;18(10 ):1171-81
19660174
Exp Neurol. 2000 Feb;161(2):503-16
10686072
Nat Neurosci. 2001 Nov;4(11):1071-8
11593232
Neuroscience. 2004;128(3):497-509
15381279
J Neurosci. 2004 Sep 8;24(36):7848-58
15356197
Neuroscience. 2000;95(3):745-52
10670441
Genes Dev. 2005 Jan 15;19(2):282-94
15655114
Cell Stem Cell. 2015 Aug 6;17 (2):195-203
26253201
Cell. 2002 Aug 9;110(3):385-97
12176325
J Neurosci. 2013 Jan 9;33(2):574-86
23303937
Prog Neurobiol. 2008 Aug;85(4):407-32
18586376
Nature. 1996 Jul 4;382(6586):80-3
8657309
Exp Neurol. 2014 Nov;261:578-93
25128265
Nat Genet. 1996 Nov;14(3):341-4
8896568
Neuron. 2001 Oct 11;32(1):99-112
11604142
Curr Gene Ther. 2015;15(3):266-76
25619885
Eur J Neurosci. 2008 Oct;28(8):1467-79
18973572
PLoS One. 2014 Oct 22;9(10):e110324
25337699
J Neurosci. 2002 May 15;22(10):3953-62
12019314
Nature. 1996 Jul 4;382(6586):76-9
8657308
Exp Neurol. 1999 Nov;160(1):28-39
10630188
IUBMB Life. 2011 Oct;63(10):930-9
21901819
PLoS One. 2012;7(7):e40154
22802953
Mol Ther. 2013 Aug;21(8):1602-10
23712039
Antioxid Redox Signal. 2009 Jul;11(7):1587-602
19413484
Nature. 1995 Jan 26;373(6512):344-6
7830769
J Neurosci. 2006 Dec 27;26(52):13413-27
17192424
Exp Neurol. 1999 Aug;158(2):504-28
10415156
Neurochem Res. 2007 Dec;32(12 ):2160-6
17594516
Chromosoma. 1997 Nov;106(6):348-60
9362543
Nature. 1996 Jul 4;382(6586):73-6
8657307
Dev Biol. 2000 Jan 1;217(1):121-37
10625540
Gastroenterology. 2010 Apr;138(4):1491-501
19944698
J Cell Biol. 1995 Jul;130(1):137-48
7790368
J Biol Chem. 2002 Mar 22;277(12):10614-25
11790765
Science. 1993 May 21;260(5111):1130-2
8493557
J Neurosci. 1996 Jul 1;16(13):4069-79
8753869
Cell Stem Cell. 2014 Jun 5;14 (6):781-95
24704492
PLoS One. 2012;7(8):e43797
22928036
Neuroscience. 2001;108(2):273-84
11734360
Science. 2014 Apr 4;344(6179):94-7
24700859
Brain Res Bull. 2000 Nov 15;53(5):547-52
11165790
J Neurosci. 2000 Dec 1;20(23):8754-61
11102483
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9092-6
7568079
Cell Tissue Res. 2008 Sep;333(3):353-71
18629541
Front Syst Neurosci. 2011 Feb 10;5:6
21347219